BeOne Medicines
The GCO Program Lead provides strategic leadership and operational oversight for global clinical programs, managing a team of Global Clinical Study Managers and ensuring successful execution of partnership studies on the Clinical SuperHighway. This role involves resource planning, budget management, cross‑functional collaboration, and mentorship to drive high‑quality clinical trial delivery.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1-10 employees
Founded
2010
BeOne Medicines, formerly BeiGene, is committed to advancing cancer care through a science‑led, purpose‑driven model that improves treatment access for patients worldwide.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for BeOne Medicines.
Director, GCO Clinical Program Lead (GCPL)
lifelancer
Director, GCO Clinical Program Lead (GCPL) – Early Phase
BeOne Medicines
Director, GCO Program Lead (GCPL)
BeOne Medicines
Global Study Associate
AstraZeneca
Associate Director, GCO Program Lead (GCPL), South Korea
BeOne Medicines
Clinical Trial Manager - CAR T or Ophthalmology
lifelancer